T
Tom Crosby
Researcher at Cardiff University
Publications - 141
Citations - 4940
Tom Crosby is an academic researcher from Cardiff University. The author has contributed to research in topics: Chemoradiotherapy & Cancer. The author has an hindex of 27, co-authored 135 publications receiving 3954 citations. Previous affiliations of Tom Crosby include Velindre NHS Trust & University Hospital of Wales.
Papers
More filters
Journal ArticleDOI
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos,John P. Neoptolemos,Daniel H. Palmer,Daniel H. Palmer,Paula Ghaneh,Eftychia E. Psarelli,Juan W. Valle,Christopher Halloran,Christopher Halloran,Olusola Olusesan Faluyi,Derek A. O'Reilly,David Cunningham,Jonathan Wadsley,Suzanne Darby,Tim Meyer,Roopinder Gillmore,Alan Anthoney,Pehr Lind,Bengt Glimelius,Stephen Falk,Jakob R. Izbicki,Gary Middleton,Sebastian Cummins,Paul Ross,Harpreet Wasan,Alec McDonald,Tom Crosby,Yuk Ting Ma,Kinnari Patel,David Sherriff,Rubin Soomal,David Borg,Sharmila Sothi,Pascal Hammel,Thilo Hackert,Richard J. Jackson,Markus W. Büchler +36 more
TL;DR: The adjuvant combination of gem citabine and capecitabine should be the new standard of care following resection for pancreatic ductal adenocarcinoma.
Journal ArticleDOI
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
T. Waddell,Ian Chau,David Cunningham,David Gonzalez,Alicia Frances Clare Okines,Andrew Wotherspoon,C. Saffery,Gary Middleton,Jonathan Wadsley,David R. Ferry,Wasat Mansoor,Tom Crosby,Fareeda Y. Coxon,David J. Smith,Justin S. Waters,Timothy Iveson,Stephen Falk,Sarah Slater,Clare Peckitt,Yolanda Barbachano +19 more
TL;DR: Addition of panitumumab to EOC chemotherapy does not increase overall survival and cannot be recommended for use in an unselected population with advanced oesophagogastric adenocarcinoma.
Journal ArticleDOI
Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer
Michael R. Stephens,Wyn G. Lewis,Alison Brewster,I. Lord,Guy Blackshaw,Ilias Hodzovic,G.V Thomas,Stuart A. G. Roberts,Tom Crosby,C. Gent,Miles C. Allison,K Shute +11 more
TL;DR: Multidisciplinary team management and surgical subspecialization improved outcomes after surgery significantly for patients diagnosed with esophageal cancer.
Journal ArticleDOI
Reporting of Short-Term Clinical Outcomes After Esophagectomy: A Systematic Review
Natalie S Blencowe,Sean Strong,Angus G K McNair,Sara T Brookes,Tom Crosby,S. Michael Griffin,Jane M Blazeby +6 more
TL;DR: Outcome reporting after esophageal cancer surgery is heterogeneous and inconsistent, and it lacks methodological rigor, so at the minimum it is recommended that a “core outcome set” is defined and used in all studies reporting outcomes of esophagectomy for cancer.
Journal ArticleDOI
Systemic treatments for metastatic cutaneous melanoma.
TL;DR: It is a pragmatic view that a future systematic review could compare any systemic treatment, or combination of treatments, to single agent dacarbazine, and to establish whether a 'standard' therapy exists which is superior to other treatments.